Search

everythinglearnresearchcommunity

for

Search:↓

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Hair loss linked to higher heart disease risk in both men and women.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Lower SHBG levels may increase the risk of PCOS.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

No cure for female pattern hair loss, but various effective treatments exist.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.